Tuesday, January 14, 2025 10:55:06 AM
You're right.
Linda Powerless is great.
Stock is doing great.
Down 60% over 52 weeks is splendid performance. What everyone has been hoping for.
Down 75% over 3 years is splendid performance. What everyone has been hoping for.
Down 87% from the 3 year high is splendid performance. What everyone has been hoping for.
Equity cut by 15% over 52 weeks is splendid performance. What everyone has been hoping for.
Equity cut by 33% over 3 years is splendid performance. What everyone has been hoping for.
4+ years since data lock and no approvals. Splendid performance, what everyone has been hoping for.
4+ years since data lock and no BLA. Splendid performance, what everyone has been hoping for.
1 press release in the last 50 WEEKS with information salient to company operations and strategy.
5 total PR's in 2024. 1 addressed a BOD change. 1 announced dilutive fundraising. 1 announced the executive bonuses. Splendid performance, what everyone has been hoping for.
I hope management never changes. Keep up this great performance. My bad for ever having the gall to challenge what they are doing with my fucking money.
Linda Powerless is great.
Stock is doing great.
Down 60% over 52 weeks is splendid performance. What everyone has been hoping for.
Down 75% over 3 years is splendid performance. What everyone has been hoping for.
Down 87% from the 3 year high is splendid performance. What everyone has been hoping for.
Equity cut by 15% over 52 weeks is splendid performance. What everyone has been hoping for.
Equity cut by 33% over 3 years is splendid performance. What everyone has been hoping for.
4+ years since data lock and no approvals. Splendid performance, what everyone has been hoping for.
4+ years since data lock and no BLA. Splendid performance, what everyone has been hoping for.
1 press release in the last 50 WEEKS with information salient to company operations and strategy.
5 total PR's in 2024. 1 addressed a BOD change. 1 announced dilutive fundraising. 1 announced the executive bonuses. Splendid performance, what everyone has been hoping for.
I hope management never changes. Keep up this great performance. My bad for ever having the gall to challenge what they are doing with my fucking money.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
